Literature DB >> 9683946

Compliance with timolol treatment in glaucoma.

A P Rotchford1, K M Murphy.   

Abstract

PURPOSE: To assess levels of compliance in elderly patients on timolol eyedrops for glaucoma.
METHODS: A postal questionnaire was sent from the general practitioner to 86 patients over 55 years of age on repeat prescriptions for timolol eyedrops. The questionnaire asked details about the duration of treatment, family history, the level of understanding of the disease and the importance of treatment, other regular medication, side-effects attributed to the drops and how often patients omitted their drops. A search of practice and local hospital dispensing data was carried out to assess how frequently monthly repeat prescriptions for timolol eyedrops were dispensed over a 12 month period. This allowed a total volume to be calculated for each patient.
RESULTS: Twenty-four per cent of patients admitted to omitting eyedrops either occasionally or frequently. Fifty-one per cent were found to have had insufficient drops dispensed to comply with treatment as prescribed. In non-complaint patients the mean period without drops was 85 days of the year, with a maximum of 165 days.
CONCLUSION: Compliance with treatment is poor and patients underestimate their level of defaulting when questioned.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683946     DOI: 10.1038/eye.1998.56

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  The influence of health literacy level on an educational intervention to improve glaucoma medication adherence.

Authors:  Kelly W Muir; Alice Ventura; Sandra S Stinnett; Abraham Enfiedjian; R Rand Allingham; Paul P Lee
Journal:  Patient Educ Couns       Date:  2011-10-13

2.  Microprocessor controlled compliance monitor for eye drop medication.

Authors:  M M Hermann; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

3.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

4.  [Preservative-containing eye drops and adherence in ophthalmological practice].

Authors:  I Lanzl; T Kaercher
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

Review 5.  [Glaucoma in the aged--barriers to understanding and compliance].

Authors:  T S Dietlein
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

6.  Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.

Authors:  Myoung Hee Park; Kyu-Dong Kang; Jungil Moon
Journal:  Jpn J Ophthalmol       Date:  2012-10-12       Impact factor: 2.447

7.  Glaucoma patients' trust in the physician.

Authors:  Kelly W Muir; Cecilia Santiago-Turla; Sandra S Stinnett; Leon W Herndon; R Rand Allingham; Pratap Challa; Paul P Lee
Journal:  J Ophthalmol       Date:  2009-10-07       Impact factor: 1.909

8.  [Telematic-assisted self-tonometry (TAS)].

Authors:  R Lämmer; M E M Groh; G Michelson
Journal:  Ophthalmologe       Date:  2004-08       Impact factor: 1.059

9.  A drug-eluting contact lens.

Authors:  Joseph B Ciolino; Todd R Hoare; Naomi G Iwata; Irmgard Behlau; Claes H Dohlman; Robert Langer; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

10.  Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.

Authors:  B Chiang; Y C Kim; A C Doty; H E Grossniklaus; S P Schwendeman; M R Prausnitz
Journal:  J Control Release       Date:  2016-02-28       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.